Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-06-08

Clinical Trial Update: The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical study assesses the impact of torasemide on hemodynamics, neurohormonal stress, and cardiac remodeling in patients with heart failure.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Torsemide (torsemide)

Snippet

Sponsor: Medical University of Warsaw | Conditions: Heart Failure | Phase 4 | Status: UNKNOWN